NCT04097379View on ClinicalTrials.gov

Safety, Tolerability and Preliminary Efficacy of Multiple Intra-articular Injections of LRX712 in Patients With Knee OA

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

July 20, 2020

Primary Completion Date

August 8, 2024

Study Completion Date

January 17, 2025

Conditions
Osteoarthritis (OA)
Interventions
DRUG

LRX712

LRX712 intra-articular injections

DRUG

Placebo

Placebo intra-articular injections

Trial Locations (1)

2333 CL

Novartis Investigative Site, Leiden

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY